Lv63
3020 积分 2025-04-20 加入
Clinical Practice Guidelines for CKD‒MBD 2025
1天前
已关闭
Complement inhibitors and B cell–modifying agents for IgA nephropathy—a Kidney Disease: Improving Global Outcomes (KDIGO) commentary
14天前
已完结
Complement inhibitors and B cell–modifying agents for IgA nephropathy—a Kidney Disease: Improving Global Outcomes (KDIGO) commentary
29天前
已完结
Renal involvement in hypereosinophilic syndrome: a systematic review with narrative synthesis of pathology, diagnosis, and therapy
1个月前
已关闭
The Effectiveness of Lesion Detection for Immunoglobulin G4-Related Kidney Diseases by Diffusion-Weighted Imaging
1个月前
已完结
Pyrimidinergic calcium signaling links tubular metabolism to fibrosis in kidney disease
2个月前
已完结
Lupus nephritis
3个月前
已完结
Lupus nephritis
3个月前
已关闭
Efficacy and safety of finerenone in non-diabetic patients with IgA nephropathy
4个月前
已完结
Effects of Therapies on Proteinuria and eGFR in IgA Nephropathy
5个月前
已完结
皖公网安备34019202002308
